Aplikace se zaměřením na LC/TOF - strana 6
Otevřít dokument High Depth Proteomics of Synovial Fluid Reveals Osteoarthritis Biomarkers
High Depth Proteomics of Synovial Fluid Reveals Osteoarthritis Biomarkers
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Iontová mobilita
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Iontová mobilita
Výrobce
Bruker
Zaměření
Proteomika
Otevřít dokument Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Targeted and Non-Targeted Screening of Persistent Organic Pollutants (POPs) in Groundwater and Trade Effluent Wastewater Using the Xevo™ G3 QTof Mass Spectrometer
Targeted and Non-Targeted Screening of Persistent Organic Pollutants (POPs) in Groundwater and Trade Effluent Wastewater Using the Xevo™ G3 QTof Mass Spectrometer
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Životní prostředí
Otevřít dokument From Extractables Screening to Targeted Leachables Quantitation Using DDA and Tof- MRM on the Xevo™ MRT Mass Spectrometer
From Extractables Screening to Targeted Leachables Quantitation Using DDA and Tof- MRM on the Xevo™ MRT Mass Spectrometer
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Sequence Confirmation of Cagrilintide Using the Agilent 1290 Infinity II Bio LC and 6545XT AdvanceBio LC/Q‑TOF
Sequence Confirmation of Cagrilintide Using the Agilent 1290 Infinity II Bio LC and 6545XT AdvanceBio LC/Q‑TOF
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Spotřební materiál, LC kolony, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
Spotřební materiál, LC kolony, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Farmaceutická analýza
Otevřít dokument Drug Screen Suite: Streamlined LC-HRMS Toxicological Screening for Routine and Post-Mortem Casework
Drug Screen Suite: Streamlined LC-HRMS Toxicological Screening for Routine and Post-Mortem Casework
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF
Výrobce
Bruker
Zaměření
Forenzní analýza a toxikologie
Otevřít dokument Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
Otevřít dokument Real-time Electron Capture Dissociation Characterization of Antibody Subunits via Microdroplet Reactions
Real-time Electron Capture Dissociation Characterization of Antibody Subunits via Microdroplet Reactions
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza
